Document is current

Any future updates will be listed below

Retraction Note to: Efficacy and safety of sofosbuvir plus ribavirin for treatment of cirrhotic patients with genotype 4 hepatitis C virus in real-life clinical practice

Crossref DOI link: https://doi.org/10.1007/s00705-022-05600-w

Published Online: 2022-09-20

Published Print: 2022-11

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark